CDC-derived exosomes (Capricor Therapeutics)

N/A

Report date: 2025/08/19 14:10:02

Base Information

Drug NameCDC-derived exosomes (Capricor Therapeutics)
Drug Alias NameN/A
ClassificationBiologics > Exosomes > Stem cell-derived exosomesCell and gene therapy > Cell therapy
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsCardiovascular DiseasesMuscular Dystrophy, Duchenne
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCapricor Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCapricor Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsCardiovascular DiseasesMuscular Dystrophy, Duchenne
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A